This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Iodine

Iodine is the single non-substitutable substrate for thyroid hormones T3 and T4 — without it, metabolism, cognition, growth, and fetal brain development all break down.

Aliases (14)
IODINE · POTASSIUM IODIDE · LUGOL'S SOLUTION · Iodide · I2 · KI · Sodium iodide · Iodine drops · Atomic iodine · Nascent iodine · Iosol · Iodoral · Prolamine iodine · Kelp iodine
TYPICAL DOSE
| Iodized table salt | KI ~76 mcg / g salt | ~1…
ROUTE
CYCLE
STORAGE

Overview

What is Iodine?

Iodine is the single non-substitutable substrate for thyroid hormones T3 and T4 — without it, metabolism, cognition, growth, and fetal brain development all break down. RDA is 150 mcg/day adults, 220 mcg pregnant, 290 mcg lactating; tolerable upper limit is 1,100 mcg/day. Most users on a typical Western diet (iodized salt, dairy, seafood, eggs, bread) get enough without supplementing. If you've migrated to Himalayan/sea/kosher salt and eat little fish, 100-200 mcg/day from a multivitamin or kelp tablet is sensible insurance — that's the bottom shelf of supplementation. The dangerous shelf is Brownstein/Abraham-style Lugol's protocols at 12.5-50 mg/day marketed in biohacker circles for "iodine deficiency epidemic" claims. These provoke Hashimoto's flares, autoimmune thyroiditis induction, iodine-induced hypothyroidism, and Jod-Basedow hyperthyroidism in susceptible individuals. The 2024 DanThyr 30-year cohort and the 2025 Khudair review confirm a clean U-shape: too little is bad; too much is also bad; the safe zone is narrow. For Dylan (20yo MMA, no thyroid disease, eats varied diet with seafood + iodized salt in some sources): OPTIONAL-ADD at 150 mcg/day in a multivitamin if currently using only non-iodized salt, otherwise dietary intake is adequate. For any user considering Lugol's mega-dose: NOT-RECOMMENDED outside physician supervision for specific indications (radiation prophylaxis, presurgical fibrocystic breast disease).

Peptide Interactions

Selenium (100-200 mcg/day, ideally as selenomethionine):
Synergistic

Mandatory co-factor for iodine utilization. Deiodinase enzymes (T4 → T3) are selenoproteins. Glutathione peroxidase (which protects thyrocytes from H₂O₂ gene…

L-Tyrosine:
Synergistic

Substrate that gets iodinated to form T4/T3. Supplementation does not affect thyroid hormone output in iodine-replete users (the rate-limiting step is iodine…

Iron (ferritin 50-100 ng/mL):
Synergistic

TPO is a heme protein; iron deficiency impairs TPO activity and worsens iodine-deficiency-related hypothyroidism. Correct iron deficiency in any iodine-relat…

Zinc (8-15 mg/day):
Synergistic

Required for thyroid hormone receptor and pituitary TSH function. Low zinc worsens hypothyroid symptoms in deficient users.

Vitamin D3:
Synergistic

Low 25(OH)D is associated with higher Hashimoto's antibody titers; correction may reduce autoimmune severity.

Vitamin A:
Synergistic

Required for TSH receptor function and thyroid hormone metabolism; severe vitamin A deficiency mimics iodine deficiency.

Amiodarone:
Avoid

Each 200 mg tablet contains 74 mg iodine (~493× RDA). Co-supplementing iodine is contraindicated. Amiodarone is itself a leading cause of iodine-induced thyr…

Lithium:
Avoid

Blocks thyroid hormone release; co-iodine supplementation can produce unpredictable thyroid swings. Lithium-induced hypothyroidism is the classic context.

Carbimazole, methimazole, propylthiouracil (PTU):
Avoid

Antithyroid drugs work by blocking TPO. Combining with iodine supplementation produces unpredictable hormone fluctuations. Should only be combined under endo…

Soy isoflavones (high-dose):
Avoid

Goitrogenic; can interfere with TPO function in iodine-deficient users. In iodine-replete users, no clinically meaningful effect at typical dietary soy intak…

Cruciferous vegetables (goitrogens — broccoli, cabbage, kale, raw):
Avoid

Theoretical concern at very high intake in iodine-deficient users; not relevant at normal dietary intake with adequate iodine.

What to Expect

  • Acute
    metallic taste, increased salivation, headache, GI upset common in first week.
  • Chronic
    (months): potential development of subclinical or overt hypothyroidism (fatigue, weight gain, cold intolerance, hair loss — exactly the symptoms the protocol…

Side Effects & Safety 11

Side Effects

  1. 1Metallic taste — universal at >1 mg/day.
  2. 2Increased salivation, "brassy" taste — common at multi-mg doses (iodine accumulation in salivary glands via NIS).
  3. 3GI upset, nausea — dose-dependent; mostly at multi-mg doses.
  4. 4Headache — common during initial 1-2 weeks of any meaningful supplementation in deficient users (often misattributed to "detox"; actually iodism).
  5. 5Acneiform eruption (iododerma) — especially common with Lugol's megadose.
  6. 6Sialadenitis (parotitis, submandibular swelling) — painful salivary gland inflammation; subsides on discontinuation.
  7. 7Rhinitis-like symptoms, increased mucus — "iodism" symptom complex.
  8. 8Conjunctival irritation, lacrimation — iodide accumulation in ciliary body.
  9. 9Hypothyroidism (iodine-induced) — in susceptible individuals (Hashimoto's, post-radioiodine, fetuses, premature infants, elderly with chronic autoimmune disease). Wolff-Chaikoff escape failure mechanism. Documented at chronic doses >1 mg/day, sometimes at lower doses in highly susceptible users.
  10. 10Hyperthyroidism (Jod-Basedow) — in individuals with autonomous nodules or latent Graves' disease. Sudden exposure to iodine load (contrast media, amiodarone, supplementation) precipitates thyrotoxicosis. Most common in older individuals with longstanding nodular goiter.
  11. 11Autoimmune thyroiditis induction or worsening — TPO antibody titer rise within weeks-to-months of high-dose iodine exposure in genetically susceptible individuals (HLA-DR3, HLA-DR5). Confirmed across multiple cohort studies and replicated in animal models (NOD-H2h4 mice, BB rats).

When to Stop

  • Severe iododerma — purpuric, vesicular, or pustular rash with systemic features; requires drug discontinuation and sometimes steroid treatment.
  • Iodine-induced thyroid storm — in latent Graves' or toxic multinodular goiter; life-threatening hyperthyroidism with tachycardia, hyperthermia, mental status changes, arrhythmia. Medical emergency.
  • Severe iodine-induced hypothyroidism with myxedema — in profoundly susceptible Hashimoto's or post-radioiodine patients on chronic high-dose iodine. Reversible on discontinuation but can be severe acutely.
  • Anaphylaxis — extremely rare; iodine itself does not cause true anaphylaxis (the "iodine allergy" label in medical charts is almost always due to shellfish proteins or contrast media excipients, not iodine atoms). However, iododerma can mimic systemic hypersensitivity.
  • Fetal hypothyroidism / goiter — maternal iodine excess in pregnancy can cross the placenta and induce fetal Wolff-Chaikoff hypothyroidism. Particular risk: maternal Lugol's use, povidone-iodine large-area topical exposure in pregnancy/lactation.
  • Papillary thyroid cancer risk — long-term cohort studies suggest higher iodine intake may shift thyroid cancer histology toward papillary type (lower-mortality) and away from follicular/anaplastic. Net effect on cancer-specific mortality is small but real. Not a reason to under-supplement, but worth understanding.
  • Hashimoto's flare with TPO/Tg antibody titer increase — documented in case literature within weeks of starting Lugol's protocol; can precipitate overt hypothyroidism in previously-compensated Hashimoto's patients.
  • Autoimmune thyroiditis induction in users without prior autoimmunity who are genetically predisposed. The 30-year DanThyr Denmark cohort and Chinese epidemiologic data establish this risk at the population level; individual risk depends on HLA + TPO genetics + selenium status.
  • Jod-Basedow hyperthyroidism in autonomous nodular disease — particularly older users with longstanding goiter or family history.
  • Reproductive impact — fetal goiter/hypothyroidism in maternal Lugol's use; documented in case reports.
  • Cosmetic / lifestyle costs — acne flare and iododerma are frequent enough to be predictable for users committing to multi-month Lugol's protocols.
  • Subclinical hypothyroidism mistaken for "detox" — Brownstein-protocol forums commonly attribute fatigue, weight gain, cold intolerance to "iodine pulling out bromine/fluoride" or "detox reactions." These are textbook iodine-induced hypothyroid symptoms. The protocol's framing actively prevents users from recognizing the iatrogenic harm.
  • Weeks 1-4 of any supplementation above 500 mcg/day: watch for headache, metallic taste, sialadenitis, acne. Reduce dose or stop if persistent.
  • Weeks 4-12 of any supplementation above 1 mg/day: check TSH and TPO antibodies — TPO antibody rise (>35-100 IU/mL) is a red flag for autoimmune induction; consider stopping.
  • Months 3-12 of chronic supplementation above 1 mg/day: annual TSH + fT4 + TPO antibody + thyroglobulin antibody monitoring; track urinary iodine if curious about absolute status.
  • Pregnancy specifically: stay within 220 mcg/day target; do not exceed 500 mcg/day even from combined sources (prenatal + diet + topical povidone-iodine).
  • Susceptible populations (Hashimoto's, post-radioiodine, fetuses, premature infants): any iodine exposure above RDA warrants endocrinology consultation. Don't self-direct.

References

Khudair A et al. 2025 — Beyond thyroid dysfunction: the systemic impact of iodine excess (Front Endocrinol)

pubmed.ncbi.nlm.nih.gov · 2025

current comprehensive review of iodine excess pathology beyond classical thyroid effects.

View Study

Ma ZF, Brough L. 2025 — Effect of Iodine Nutrition During Pregnancy and Lactation on Child Cognitive Outcomes (Nutrients)

pubmed.ncbi.nlm.nih.gov · 2025

U-shape established in maternal iodine + offspring cognition.

View Study

Bryliński Ł et al. 2025 — Effects of Trace Elements on Endocrine Function and Pathogenesis of Thyroid Diseases (Nutrients)

pubmed.ncbi.nlm.nih.gov · 2025

iodine, selenium, zinc, iron, copper interplay in thyroid pathogenesis.

View Study

Tang Møllehave L, Knudsen N et al. 2024 — DanThyr: history and implications (Eur Thyroid J)

pubmed.ncbi.nlm.nih.gov · 2024

30-year Danish cohort synthesis of cautious iodine fortification and thyroid disease.

View Study

Leung AM, Braverman LE. 2014 — Consequences of excess iodine (Nat Rev Endocrinol, PMID 24342882)

pubmed.ncbi.nlm.nih.gov · 2014

canonical review of iodine excess.

View Study
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources